Being told your uterine lining isn't thick enough for embryo transfer is one of the most deflating moments in an IVF cycle. You've made it through stimulation, retrieval, fertilisation — and then, at the final hurdle before transfer, the scan shows a lining that won't cooperate. It's a problem that's more common than most patients realise, more treatable than most clinics acknowledge, and one that Hanabusa IVF in San Diego has significant experience navigating.
What Is a Thin Uterine Lining — and Why Does It Matter?
The uterine lining — the endometrium — is a dynamic tissue that thickens across the menstrual cycle under the influence of oestrogen and progesterone. In an IVF cycle, adequate lining development is essential for embryo implantation. An embryo, however chromosomally perfect, cannot implant successfully into a lining that is too thin or structurally inadequate.
The threshold most reproductive endocrinologists use is a minimum endometrial thickness of 7mm, measured by transvaginal ultrasound. Most specialists prefer 8mm or above before transfer, and many aim for 9–10mm or more. A lining below 7mm is associated with significantly reduced implantation rates. But thickness is not the only variable — pattern matters too. A trilaminar (triple-line) pattern indicates a well-developed, receptive endometrium; a thin featureless lining carries lower implantation potential even above the threshold measurement.
A thin uterine lining — defined as less than 7mm at the time of embryo transfer — is associated with significantly lower implantation rates and higher cycle cancellation rates in IVF. However, thin lining is rarely untreatable. The key is identifying the underlying cause and applying the right intervention — not simply cancelling the cycle and trying the same approach again.
What Causes a Thin Uterine Lining?
Insufficient oestrogen stimulation: The endometrium develops in response to oestradiol. If oestrogen levels are inadequate, or if the endometrium's oestrogen receptors are damaged or dysfunctional, the lining will not thicken appropriately even with standard supplementation.
Poor uterine blood flow: The endometrium requires robust blood supply for adequate development. Reduced subendometrial blood flow — measurable on Doppler ultrasound — is associated with thin lining and poor receptivity. Causes include previous uterine surgery, fibroids, adenomyosis, and chronic conditions such as hypertension.
Asherman's syndrome (intrauterine adhesions): Scarring inside the uterine cavity — most commonly from previous D&C, uterine surgery, or infection — can physically prevent the endometrium from developing. Asherman's syndrome ranges from mild adhesions to extensive scarring and may require hysteroscopic surgery before fertility treatment is possible.
Adenomyosis: As discussed in the previous article in this series (Adenomyosis and Fertility: What It Means for Your Chances of Getting Pregnant), adenomyosis disrupts uterine blood flow and the structural integrity of the myometrium in ways that directly impair endometrial development. Thin lining in the context of adenomyosis is a particularly common clinical picture requiring an adenomyosis-specific management strategy alongside lining treatment.
Clomiphene use: Clomiphene citrate has anti-oestrogenic effects on the endometrium that can paradoxically thin the lining even as it stimulates egg production. This is one of the reasons Hanabusa favours letrozole-based mini IVF protocols — letrozole does not carry the same anti-oestrogenic endometrial effects.
Prior uterine infection: Chronic endometritis — inflammation of the uterine lining — can damage the endometrial glands and stromal cells that drive lining development. It is more common than previously recognised and may be present without obvious symptoms.
The Science Behind Treatment
A 2019 systematic review in Reproductive BioMedicine Online examined interventions for thin endometrium across multiple randomised and controlled trials. The review found that no single intervention was universally effective — underlining that thin lining is a heterogeneous problem requiring cause-specific management — but identified several interventions with meaningful evidence of benefit:
Extended or modified oestrogen protocols: Adjusting the type (oral, transdermal, or vaginal oestrogen), dose, and duration can improve lining development in patients with inadequate response. Some patients respond better to transdermal or vaginal oestrogen when oral preparations have been insufficient.
Low-dose aspirin: Aspirin at low doses (75–100mg daily) improves uterine blood flow by inhibiting thromboxane-mediated vasoconstriction and enhancing prostacyclin-mediated vasodilation. It has a reasonable evidence base, particularly for patients with suboptimal Doppler blood flow measurements.
Sildenafil: A 2002 study in Fertility and Sterility found that vaginal sildenafil improved uterine blood flow and endometrial thickness in women with thin lining unresponsive to oestrogen. Its vasodilatory effects extend to uterine vasculature when administered vaginally, and subsequent clinical experience has reinforced its utility in this context.
Platelet-Rich Plasma (PRP) intrauterine infusion: PRP contains concentrated growth factors — including VEGF, PDGF, EGF, and TGF-β — that promote angiogenesis, tissue regeneration, and cellular proliferation in the endometrium. A 2025 meta-analysis in the Journal of Pharmacy & BioAllied Sciences found that intrauterine PRP infusion significantly improved endometrial thickness and clinical pregnancy rates in women with refractory thin endometrium compared to control groups. Hanabusa IVF offers PRP intrauterine infusion as part of its endometrial management programme.
G-CSF (granulocyte colony-stimulating factor): G-CSF is a cytokine that promotes endometrial growth and receptivity through multiple mechanisms. It has been studied as an intrauterine infusion for thin endometrium and has shown benefit in several randomised trials, particularly for Asherman's-related or refractory thin lining.
Hysteroscopic adhesiolysis: For women with Asherman's syndrome, hysteroscopic surgery to divide adhesions and restore the uterine cavity is the appropriate first step — without which no medical treatment will adequately address the underlying structural problem.
What Hanabusa's Approach Looks Like
At Hanabusa IVF, thin uterine lining is never treated as a reason to abandon a cycle without investigation. Before any transfer is scheduled, endometrial development is monitored carefully — thickness, pattern, and Doppler blood flow. If lining development is insufficient, the cycle is adapted rather than simply cancelled.
The first step is understanding why. A thorough review of the patient's history — prior surgeries, prior cycles, hormonal responses, ultrasound patterns — combined with additional investigation where indicated (including hysteroscopy, ERA testing, or chronic endometritis evaluation) provides the clinical basis for a targeted plan.
From there, the intervention is chosen for the individual: whether that means a modified oestrogen protocol, low-dose aspirin, vaginal sildenafil, PRP infusion, or a combination. For patients where adenomyosis is the underlying driver, the treatment plan integrates the hormonal downregulation and uterine preparation strategies — because thin lining in adenomyosis is a downstream consequence of the uterine wall disruption, not an independent problem.
Dr Chang and Dr LeBlanc's collective experience in complex uterine cases means that thin lining patients at Hanabusa are not navigating a standard protocol with bolt-on adjuncts. They are receiving a genuinely personalised uterine management plan — designed around the specific cause of their lining problem, their full clinical history, and their individual response at each monitoring appointment.
Frequently Asked Questions
What is the minimum endometrial thickness for embryo transfer?
Most specialists set a minimum threshold of 7mm, with a preference for 8mm or above. However, thickness alone is not the complete picture — a well-patterned lining of 7.5mm may be preferable to a featureless lining of 8.5mm. Hanabusa evaluates both thickness and pattern before making transfer decisions.
How many cycles of treatment might it take to achieve adequate lining?
This depends heavily on the underlying cause. Women with simple oestrogen-responsive thin lining may achieve adequate thickness with protocol adjustment in the same or next cycle. Women with Asherman's syndrome may require surgical intervention followed by healing time. Women with adenomyosis may need extended hormonal downregulation. There is no universal timeline — the Hanabusa team sets realistic expectations at consultation.
Can PRP treatment be done in the same cycle as transfer?
PRP intrauterine infusion is typically performed 48–72 hours before a planned embryo transfer, or earlier in the cycle to allow time for endometrial response. Hanabusa coordinates PRP timing as part of the integrated transfer preparation plan.
Is thin lining always caused by something treatable?
In the vast majority of cases, yes — thin lining has an identifiable underlying cause and a corresponding treatment approach. True refractory thin endometrium — where the lining fails to develop despite comprehensive treatment — is uncommon. When it does occur, gestational surrogacy is the alternative pathway that Hanabusa can help navigate, through its sister practice New England Fertility Institute in Stamford, Connecticut.
Should I have a hysteroscopy before my next IVF cycle if my lining has been thin?
If Asherman's syndrome, a uterine abnormality, or chronic endometritis is suspected and has not been ruled out, hysteroscopy is often the most informative next step. Hanabusa evaluates this as part of the workup for patients with a history of thin lining.
The Lining Is Not the End of the Story
A thin uterine lining is a challenge — but it is rarely the end of the road. At Hanabusa IVF, we approach every difficult case with the same conviction: there is almost always something more to try, something more to understand, and a pathway forward that hasn't been fully explored yet. Whether you're coming to us with endometriosis, adenomyosis, thin lining, or all three — we're here to look at the full picture and build a plan that is genuinely yours.
This is the final article in a three-part series on complex uterine and ovarian conditions in IVF. If you arrived here directly, we'd encourage you to start from the beginning — with Endometriosis and IVF: Why Mini Stimulation May Give You a Better Chance, followed by Adenomyosis and Fertility: What It Means for Your Chances of Getting Pregnant. Together, the three articles provide the most complete picture of how these conditions interact and how Hanabusa approaches them as a whole.
